Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Total Assets (Quarterly): 822.10M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 822.10M |
| June 30, 2023 | 714.33M |
| March 31, 2023 | 288.34M |
| December 31, 2022 | 348.94M |
| September 30, 2022 | 358.80M |
| June 30, 2022 | 422.30M |
| March 31, 2022 | 481.71M |
| December 31, 2021 | 525.76M |
| September 30, 2021 | 296.80M |
| June 30, 2021 | 301.45M |
| March 31, 2021 | 345.96M |
| December 31, 2020 | 355.07M |
| September 30, 2020 | 247.95M |
| June 30, 2020 | 269.73M |
| March 31, 2020 | 298.81M |
| December 31, 2019 | 235.26M |
| September 30, 2019 | 254.14M |
| June 30, 2019 | 287.67M |
| March 31, 2019 | 323.92M |
| December 31, 2018 | 295.38M |
| September 30, 2018 | 339.86M |
| June 30, 2018 | 381.08M |
| March 31, 2018 | 264.96M |
| December 31, 2017 | 294.68M |
| September 30, 2017 | 225.70M |
| Date | Value |
|---|---|
| June 30, 2017 | 181.38M |
| March 31, 2017 | 163.32M |
| September 30, 2016 | 231.35M |
| June 30, 2016 | 279.24M |
| March 31, 2016 | 222.35M |
| December 31, 2015 | 251.58M |
| September 30, 2015 | 285.58M |
| June 30, 2015 | 308.25M |
| March 31, 2015 | 133.80M |
| December 31, 2014 | 128.54M |
| September 30, 2014 | 143.11M |
| June 30, 2014 | 165.32M |
| March 31, 2014 | 186.69M |
| December 31, 2013 | 202.52M |
| September 30, 2013 | 200.02M |
| June 30, 2013 | 213.60M |
| March 31, 2013 | 228.68M |
| December 31, 2012 | 230.84M |
| September 30, 2012 | 252.67M |
| June 30, 2012 | 180.31M |
| March 31, 2012 | 196.33M |
| December 31, 2011 | 208.22M |
| September 30, 2011 | 199.10M |
| June 30, 2011 | 217.64M |
| March 31, 2011 | 142.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
235.26M
Minimum
Dec 2019
822.10M
Maximum
Sep 2023
380.84M
Average
323.70M
Median
Total Assets (Quarterly) Benchmarks
| AbbVie Inc | 134.71B |
| Pfizer Inc | 226.50B |
| Johnson & Johnson | 171.97B |
| Merck & Co Inc | 106.68B |
| Cerevel Therapeutics Holdings Inc | 1.243B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 260.50M |
| Shareholders Equity (Quarterly) | 561.60M |
| Debt to Equity Ratio | 0.1284 |
| Current Ratio | 5.695 |
| Net Debt Paydown Yield | -0.34% |